OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Stephen Salton

1 Projects | 1 Researchers | $158,171 Invested

2015

Icahn School of Medicine at Mount Sinai

Stephen Salton, MD, PhD

VGF peptide delivery for the suppression of memory impairment in an Alzheimer's disease model

  • Funding Amount: $158,171
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Growth Factors/Neurotrophic Factors
  • Status: Closed